These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11252012)

  • 1. Simultaneous comparison of sensitivity and specificity of two tests in the paired design: a straightforward graphical approach.
    Newcombe RG
    Stat Med; 2001 Mar; 20(6):907-15. PubMed ID: 11252012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the gain in diagnostic performance when combining two diagnostic tests.
    Macaskill P; Walter SD; Irwig L; Franco EL
    Stat Med; 2002 Sep; 21(17):2527-46. PubMed ID: 12205697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some issues in resolution of diagnostic tests using an imperfect gold standard.
    Hawkins DM; Garrett JA; Stephenson B
    Stat Med; 2001 Jul; 20(13):1987-2001. PubMed ID: 11427955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new occult blood test not subject to false-negative results from reducing substances.
    Jaffe RM; Zierdt W
    J Lab Clin Med; 1979 May; 93(5):879-86. PubMed ID: 429880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower specificity of occult-blood test on stool collected by digital rectal examination.
    Zhang B; Nakama H; Fattah AS; Kamijo N
    Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification bias-corrected estimators of the relative true and false positive rates of two binary screening tests.
    Alonzo TA
    Stat Med; 2005 Feb; 24(3):403-17. PubMed ID: 15543634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of false results in tests for occult blood in feces].
    Zwillenberg LO
    Schweiz Rundsch Med Prax; 1990 Apr; 79(17):521-3. PubMed ID: 2187220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of urine dipsticks, 2-h and 12-h urine collections for protein measurement as compared with the 24-h collection.
    Abebe J; Eigbefoh J; Isabu P; Okogbenin S; Eifediyi R; Okusanya B
    J Obstet Gynaecol; 2008 Jul; 28(5):496-500. PubMed ID: 18850422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of three stool tests for colorectal cancer screening.
    Greenwald B
    Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do dietary restrictions reduce fecal occult blood testing adherence?
    Richardson CR
    J Fam Pract; 2001 Dec; 50(12):1081. PubMed ID: 11742613
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of contrast enhanced CT colonography and conventional colonoscopy for detection of colorectal neoplasms in a single institutional study using second-look colonoscopy with discrepant results.
    Hoppe H; Netzer P; Spreng A; Quattropani C; Mattich J; Dinkel HP
    Am J Gastroenterol; 2004 Oct; 99(10):1924-35. PubMed ID: 15447751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
    Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
    J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reviewing interval cancers: time well spent?
    Gower-Thomas K; Fielder HM; Branston L; Greening S; Beer H; Rogers C
    Clin Radiol; 2002 May; 57(5):384-8. PubMed ID: 12014936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the likelihood ratios of two binary diagnostic tests in paired designs.
    Nofuentes JA; Del Castillo Jde D
    Stat Med; 2007 Sep; 26(22):4179-201. PubMed ID: 17357992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.